Almuneef Company for Trade, Industry, Agriculture and Contracting (9569.SR)
SAR 6.49
(-2.99%)
SAR 6.49
(-2.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 246.29 Million | 318.43 Million | 187.75 Million | 142.44 Million |
| Cost of Revenue | 219 Million | 285.79 Million | 161.57 Million | 114.02 Million |
| Gross Profit | 27.29 Million | 32.63 Million | 26.17 Million | 28.42 Million |
| Operating Expenses | 8.06 Million | 9.84 Million | 5.76 Million | 7.1 Million |
| Selling, General and Administrative Expenses | 5.65 Million | 4.45 Million | 4.76 Million | 7.1 Million |
| Research and Development Expenses | - | - | - | - |
| Other Expenses | 2.41 Million | 223.3 Thousand | -1 Million | - |
| Cost and Expenses | 226.42 Million | 295.64 Million | 167.34 Million | 121.13 Million |
| Operating Income | 19.87 Million | 22.51 Million | 20.41 Million | 21.31 Million |
| Interest Expense | 232.35 Thousand | 201.05 Thousand | 293.75 Thousand | 189.01 Thousand |
| Income Tax Expense | 2.41 Million | 1.77 Million | 1.06 Million | 799.09 Thousand |
| Earnings before Tax | 19.99 Million | 22.39 Million | 20.73 Million | 21.42 Million |
| Net Income | 17.58 Million | 20.62 Million | 19.67 Million | 20.62 Million |
| Earnings Per Share Basic | 4.63 | 5.43 | 5.18 | 5.43 |
| Earnings Per Share Diluted | 4.63 | 5.43 | 5.18 | 5.43 |
| Weighted Average Shares Outstanding | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million |
| Gross Margin | 0.11 | 0.10 | 0.14 | 0.20 |
| EBIT Margin | 0.11 | 0.09 | 0.15 | 0.20 |
| Profit Margin | 0.07 | 0.06 | 0.10 | 0.14 |
| EBITDA | 27.33 Million | 29.9 Million | 28.04 Million | 28.32 Million |
| Earnings Before Tax Margin | 0.08 | 0.07 | 0.11 | 0.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 56.7 Million | 56.7 Million | 246.29 Million | 121.95 Million | 60.97 Million | 124.33 Million |
| Cost of Revenue | 50.18 Million | 50.18 Million | 219 Million | 108.2 Million | 54.1 Million | 110.15 Million |
| Gross Profit | 6.51 Million | 6.51 Million | 27.29 Million | 13.75 Million | 6.87 Million | 14.18 Million |
| Operating Expenses | 1.04 Million | 1.04 Million | 7.23 Million | 4.75 Million | 2.35 Million | 3.31 Million |
| Selling, General and Administrative Expenses | 887.59 Thousand | 887.59 Thousand | - | 4.75 Million | 1.17 Million | 3.31 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 156.59 Thousand | 156.59 Thousand | -838.31 Thousand | - | - | - |
| Cost and Expenses | 51.23 Million | 51.23 Million | 226.23 Million | 112.96 Million | 56.45 Million | 113.46 Million |
| Operating Income | 5.47 Million | 5.47 Million | 20.06 Million | 8.99 Million | 4.98 Million | 10.87 Million |
| Interest Expense | 76.3 Thousand | - | 232.35 Thousand | 140.78 Thousand | - | 91.56 Thousand |
| Income Tax Expense | 436.2 Thousand | 436.2 Thousand | 2.41 Million | 1.91 Million | 956.06 Thousand | 500 Thousand |
| Earnings before Tax | 5.56 Million | 5.56 Million | 19.99 Million | 8.95 Million | 4.47 Million | 11.04 Million |
| Net Income | 5.12 Million | 5.12 Million | 17.58 Million | 7.03 Million | 3.51 Million | 10.54 Million |
| Earnings Per Share Basic | 1.35 | 1.35 | - | 1.85 | 0.93 | 2.77 |
| Earnings Per Share Diluted | 1.35 | 1.35 | - | 1.85 | 0.93 | 2.77 |
| Weighted Average Shares Outstanding | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million | 3.8 Million |
| Gross Margin | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 | 0.11 |
| EBIT Margin | 0.12 | 0.12 | - | 0.10 | 0.11 | 0.12 |
| Profit Margin | 0.09 | 0.09 | 0.07 | 0.06 | 0.06 | 0.08 |
| EBITDA | 6.97 Million | 6.97 Million | - | 12.51 Million | 6.49 Million | 14.32 Million |
| Earnings Before Tax Margin | 0.10 | 0.10 | 0.08 | 0.07 | 0.08 | 0.09 |
MANBRO
FMII
002820
ORISSAMINE
DHARFIN
SIG